SCHEDULE: Ameriprise Financial Boosts Quanterix Stake to 10.7%

Ameriprise Financial, Inc. and its subsidiaries have reported a beneficial ownership of 10.7% in Quanterix Corp. common stock as of December 31, 2025.

Summary

• Ameriprise Financial, Inc. and its affiliated entities collectively beneficially own 4,996,073 shares of Quanterix Corp. common stock.
• This aggregate ownership represents 10.7% of Quanterix Corp.'s outstanding common stock.
• Ameriprise Financial, Inc. holds shared voting power over 4,986,032 shares and shared dispositive power over 4,996,073 shares.
• TAM UK International Holdings Limited, a subsidiary, beneficially owns 3,122,967 shares, representing 6.7% of the class.
• Threadneedle Management Luxembourg S.A., another subsidiary, beneficially owns 1,894,013 shares, representing 4.1% of the class.
• Other Threadneedle entities (Threadneedle Holdings Limited, TAM UK Holdings Limited, Threadneedle Asset Management Holdings Limited, TC Financing Ltd, Threadneedle Asset Management Limited, Threadneedle Investment Services Limited) each report beneficial ownership of 1,228,954 shares, representing 2.6% of the class, which are included in the overall Ameriprise Financial, Inc. total.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development. A significant increase in institutional ownership by a reputable financial entity like Ameriprise Financial suggests a vote of confidence in Quanterix Corp.'s value proposition and future prospects, which can be a bullish signal for investors.

Positives

• Increased institutional ownership by a major financial institution like Ameriprise Financial can signal confidence in Quanterix Corp.'s long-term prospects.
• A significant stake by a reputable asset manager may attract further institutional interest and potentially stabilize the stock price.

Negatives

• NA

Risks

• NA

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Quanterix Corp.'s future performance or outlook.

Management Comments

• Ameriprise Financial, Inc. and its subsidiaries certify that the securities were acquired and are held in the ordinary course of business.
• The reporting persons certify that the securities were not acquired or held for the purpose or with the effect of changing or influencing the control of Quanterix Corp., nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

StockSavvy.ai notes that a substantial increase in beneficial ownership by a major financial services company like Ameriprise Financial, through its various asset management subsidiaries, often indicates a positive long-term view on the issuer's industry position and growth potential. This move suggests that large institutional investors are actively positioning themselves in companies like Quanterix Corp., which operates in the diagnostics and life sciences sector, potentially anticipating future growth in precision medicine or related fields.

Comparison to Industry Standards

• Institutional ownership levels vary significantly across industries and company sizes. A 10.7% stake by a single institutional group is a notable position, indicating a high conviction investment.
• For comparison, similar-sized biotech or diagnostic companies often see significant institutional holdings, with top-tier asset managers frequently holding stakes ranging from 5% to over 15% in companies they view as having strong growth trajectories or strategic value.

Stakeholder Impact

• Shareholders: The increased institutional ownership could be seen as a positive signal, potentially leading to increased investor confidence and demand for the stock.
• Company Management: A large institutional holder may exert influence on corporate governance and strategic decisions, though the filing explicitly states the shares were not acquired for control purposes.

Key Dates

Recommendation

The significant increase in institutional ownership by Ameriprise Financial is a positive indicator, suggesting confidence from a major player. However, a Schedule 13G filing primarily reports ownership and does not provide new operational or financial performance data for Quanterix Corp. While the institutional backing is favorable, a 'hold' recommendation is appropriate until further fundamental analysis, including recent financial results and strategic updates from Quanterix Corp., can be conducted to assess the company's intrinsic value and future growth prospects.

Keywords

Quanterix Corp, Ameriprise Financial, Institutional Ownership, Beneficial Ownership, Common Stock, SEC Filing, Investment, Asset Management, Healthcare Technology